Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats
dc.contributor.author | Villicev C.M. | |
dc.contributor.author | Freitas F.R.S. | |
dc.contributor.author | Aoki M.S. | |
dc.contributor.author | Taffarel C. | |
dc.contributor.author | Scanlan T.S. | |
dc.contributor.author | Moriscot A.S. | |
dc.contributor.author | Ribeiro M.O. | |
dc.contributor.author | Bianco A.C. | |
dc.contributor.author | Gouveia C.H.A. | |
dc.date.accessioned | 2024-03-13T01:40:00Z | |
dc.date.available | 2024-03-13T01:40:00Z | |
dc.date.issued | 2007 | |
dc.description.abstract | It is well known that thyroid hormone affects body composition; however, the effect of the thyroid hormone receptor β (TRβ)-selective thyromimetic GC-1 on this biological feature had not been demonstrated. In the current study, we compared the effects of a 6-week treatment with triiodothyronine (T3; daily injections of 3 or 6 μg/100 g body weight) or GC-1 (equimolar doses) on different metabolic parameters in adult female rats. Whereas all animals gained weight (17-25 g) in a way not basically affected by T3 or GC-1 treatment, only T3 treatment selectively increased food intake (50-70%). Oxygen consumption was significantly and equally increased (50-70%) by T3 and GC-1. Analysis of body composition by dual-energy X-ray absorptiometry (DEXA) revealed that, whereas control animals gained about 80% of fat mass, T3- or GC-1-treated animals lost 70-90 and ∼20% respectively. Direct analysis of the carcass showed that T3 treatment promoted a 14-74% decrease in fat content but GC-1 treatment promoted only a 15-23% reduction. The gain in lean mass by DEXA and the carcass protein content were not affected by T3 or GC-1 treatment. However, the mass of individual skeletal muscles was negatively affected by T3 but only barely by GC-1. These findings highlight the potential use of GC-1 for the treatment of obesity and the metabolic syndrome. © 2007 Society for Endocrinology. | |
dc.description.firstpage | 21 | |
dc.description.issuenumber | 1 | |
dc.description.lastpage | 29 | |
dc.description.volume | 193 | |
dc.identifier.doi | 10.1677/joe.1.07066 | |
dc.identifier.issn | 0022-0795 | |
dc.identifier.uri | https://dspace.mackenzie.br/handle/10899/37655 | |
dc.relation.ispartof | Journal of Endocrinology | |
dc.rights | Acesso Aberto | |
dc.title | Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats | |
dc.type | Artigo | |
local.scopus.citations | 95 | |
local.scopus.eid | 2-s2.0-34247344167 | |
local.scopus.updated | 2024-05-01 | |
local.scopus.url | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34247344167&origin=inward |